Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Study for Schizophrenia Relapse Prediction

NCT03629951 is registered in ClinicalTrials.gov with Janssen Research & Development, LLC as lead sponsor.

NCT NCT03629951
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03629951 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Study for Schizophrenia Relapse Prediction
Lead sponsor
Janssen Research & Development, LLC
Phase
Observational
Overall status
Completed
Start date
November 29, 2018
Completion date
December 31, 2021
Enrollment
333 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia